|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| C07F 9/4003 | (2013.01) | ||
| C07D 471/00 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 401/04 | (2013.01) | ||
| C07F 5/025 | (2013.01) | ||
| C07F 9/00 | (2013.01) | ||
| C07F 9/091 | (2013.01) | ||
| C07F 9/1651 | (2013.01) | ||
| C07F 9/3826 | (2013.01) | ||
| C07F 9/4407 | (2013.01) |
| (11) | Number of the document | 3678668 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18779884.8 |
| Date of filing the European patent application | 2018-09-07 | |
| (97) | Date of publication of the European application | 2020-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/050018 |
| Date | 2018-09-07 |
| (87) | Number | WO 2019/051269 |
| Date | 2019-03-14 |
| (30) | Number | Date | Country code |
| 201762556117 P | 2017-09-08 | US |
| (72) |
LI, Lingyin , US
SMITH, Mark , US
SHAW, Kelsey Erin , US
CAROZZA, Jacqueline Ann , US
BOEHNERT, Volker , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER |
| ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER |